Back to User profile » Dr Zhi-Qing Zhao
Papers published by Dr Zhi-Qing Zhao:
Attenuation of Myocardial Fibrosis with Curcumin Is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats [Corrigendum]
Pang X, Zhang L, Bai F, Wang N, Garner RE, McKallip R, Zhao Z
Drug Design, Development and Therapy 2020, 14:2515-2516
Published Date: 26 June 2020
Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
Zheng RH, Bai XJ, Zhang WW, Wang J, Bai F, Yan CP, James EA, Bose HS, Wang NP, Zhao Z
Drug Design, Development and Therapy 2019, 13:2745-2757
Published Date: 6 August 2019
Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
Zhang WW, Bai F, Wang J, Zheng RH, Yang LW, James EA, Zhao ZQ
Drug Design, Development and Therapy 2017, 11:3019-3033
Published Date: 16 October 2017
Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats
Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, Zhao ZQ
Drug Design, Development and Therapy 2015, 9:6043-6054
Published Date: 11 November 2015